Rbc Life Sciences Stock Market Value
| RBCL Stock | USD 0.0006 0.00 0.00% |
| Symbol | RBC |
RBC Life 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RBC Life's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RBC Life.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in RBC Life on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding RBC Life Sciences or generate 0.0% return on investment in RBC Life over 90 days. RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in Nor... More
RBC Life Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RBC Life's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RBC Life Sciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1643 | |||
| Maximum Drawdown | 100.0 |
RBC Life Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RBC Life's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RBC Life's standard deviation. In reality, there are many statistical measures that can use RBC Life historical prices to predict the future RBC Life's volatility.| Risk Adjusted Performance | 0.1343 | |||
| Jensen Alpha | 2.58 | |||
| Total Risk Alpha | 1.02 | |||
| Treynor Ratio | (0.80) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of RBC Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
RBC Life January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1343 | |||
| Market Risk Adjusted Performance | (0.79) | |||
| Mean Deviation | 4.61 | |||
| Coefficient Of Variation | 587.78 | |||
| Standard Deviation | 13.99 | |||
| Variance | 195.85 | |||
| Information Ratio | 0.1643 | |||
| Jensen Alpha | 2.58 | |||
| Total Risk Alpha | 1.02 | |||
| Treynor Ratio | (0.80) | |||
| Maximum Drawdown | 100.0 | |||
| Skewness | 6.3 | |||
| Kurtosis | 41.3 |
RBC Life Sciences Backtested Returns
RBC Life is out of control given 3 months investment horizon. RBC Life Sciences retains Efficiency (Sharpe Ratio) of 0.17, which implies the company had a 0.17 % return per unit of risk over the last 3 months. We were able to break down seventeen different technical indicators, which can help you to evaluate if expected returns of 2.38% are justified by taking the suggested risk. Use RBC Life Sciences coefficient of variation of 587.78, and Market Risk Adjusted Performance of (0.79) to evaluate company specific risk that cannot be diversified away. RBC Life holds a performance score of 13 on a scale of zero to a hundred. The firm owns a Beta (Systematic Risk) of -2.95, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning RBC Life are expected to decrease by larger amounts. On the other hand, during market turmoil, RBC Life is expected to outperform it. Use RBC Life Sciences information ratio, as well as the relationship between the kurtosis and relative strength index , to analyze future returns on RBC Life Sciences.
Auto-correlation | 0.00 |
No correlation between past and present
RBC Life Sciences has no correlation between past and present. Overlapping area represents the amount of predictability between RBC Life time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RBC Life Sciences price movement. The serial correlation of 0.0 indicates that just 0.0% of current RBC Life price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in RBC Pink Sheet
RBC Life financial ratios help investors to determine whether RBC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Life security.